Lactose (India) Ltd.
Snapshot View

View in App

Prices View details >>

69.60 +1.80 ▲2.7%

30 September 2022, 12:36:00 PM
Volume: 530

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lactoseindialimited.com
Market Cap 87.81 Cr.
Enterprise Value(EV) 124.74 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 2.54 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 27.50 Trailing Twelve Months Ending 2022-06
Industry PE 31.29 Trailing Twelve Months Ending 2022-06
Book Value / Share 31.27 Trailing Twelve Months Ending 2022-06
Price to Book Value 2.23 Calculated using Price: 69.75
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.26 Cr. 12,589,000 Shares
FaceValue 10
Company Profile
Lactose (India), a Toshniwal Group company, was incorporated in 1991, under the Companies Act, 1956. Its plant in Vadodara, Gujarat was commissioned by Alfa Laval, Pune (which is a subsidary of Alfa Laval of Sweden) and was also given a ‘thumbs up' by reputed dairy experts from the Netherlands in October 1991. Subsequently Alfa Laval, reputed dairy experts from Sweden and a joint commission from the Netherlands studied the plant and its working and confidently acknowledged the plant for its quality standards as well.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.65%
1 Week
+0.43%
1 Month
-2.52%
3 Month
+9.87%
6 Month
+20.31%
1 Year
+72.28%
2 Year
+252.41%
5 Year
-60.22%
10 Year
+873.43%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 0.18 3.25 15.69 11.95 -4.59 2.20 0.21 -7.21 6.65
Return on Capital Employed (%) 3.69 7.55 14.75 14.78 4.08 9.13 7.84 2.81 10.21
Return on Assets (%) 0.05 0.71 3.44 3.30 -1.59 0.88 0.09 -2.88 2.75

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 15 15 16 20 27 32 34 34 35 39
Non Curr. Liab. 15 30 44 37 31 38 35 38 42 36
Curr. Liab. 17 16 20 26 27 13 12 11 12 15
Minority Int.
Equity & Liab. 47 60 80 83 85 83 82 84 88 90
Non Curr. Assets 27 47 67 66 68 66 64 64 69 67
Curr. Assets 20 13 13 17 17 17 18 20 20 23
Misc. Exp. not W/O
Total Assets 47 60 80 83 85 83 82 84 88 90

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 22 24 34 36 31 41 40 35 46 47
Other Income 1 0 1 1 1 0 0 0 1 1
Total Income 23 24 36 37 32 41 40 35 47 48
Total Expenditure -21 -19 -24 -24 -25 -31 -31 -29 -34 -34
PBIDT 2 5 12 12 6 10 10 7 13 14
Interest -1 -3 -4 -4 -5 -5 -6 -5 -5 -5
Depreciation -2 -2 -3 -3 -4 -4 -4 -4 -5 -5
Taxation 0 0 -1 -2 1 0 0 1 -1 -1
Exceptional Items 2
PAT 0 1 3 3 -1 1 0 -2 2 3
Adjusted EPS 0 1 3 3 -1 1 0 -2 2 3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 14 7 13 1 8 0 5 7 2 8
Cash Fr. Inv. -14 -21 -23 3 -5 -2 -2 -3 -6 -1
Cash Fr. Finan. 1 13 10 -5 -3 4 -5 -4 5 -8
Net Change 1 -1 -1 0 0 3 -2 1 1 0
Cash & Cash Eqvt 1 1 0 0 0 3 1 2 2 2

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 42.90 42.90 42.90 49.13 49.13 49.13 52.50 53.79 53.79
Public 57.10 57.10 57.10 50.87 50.87 50.87 47.50 46.21 46.21
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 3.94 60.61 60.61 47.15 47.15 47.15 41.21 39.13 0.52

Announcements View Details >>

Fri, 09 Sep 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed Intimation towards loss of Share Certificate as per the captioned regulation.
Tue, 06 Sep 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed Intimation towards loss of Share Certificate as per the captioned regulation.
Wed, 10 Aug 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
In terms of Regulation 30 and Regulation 47(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (LODR) please find attached newspaper cuttings of the advertisement in relation to the financial results for the First quarter ended on 30th June 2022 as specified in Regulation 33 of LODR published in Business Standard (English) and Baroda Samachar on 10th August 2022 and the same is also being displayed on the website of the Company viz www.lactoseindialimited.com.

Technical Scans View Details >>

Thu, 29 Sep 2022
High Delivery Percentage High Delivery Percentage
Close Crossing Last Week Low Close Crossing Last Week Low
High Decrease 1 Month High Decrease 1 Month
High Increase 3 Months High Increase 3 Months
High Increase 1 Year High Increase 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 223,330.10 944.95 +1.5%
Divi's Laboratories Ltd. 97,819.86 3,699.80 +0.2%
Cipla Ltd. 90,339.79 1,118.00 +0.2%
Dr. Reddy's Laboratories Ltd. 72,565.89 4,328.00 -0.8%
Apollo Hospitals Enterprise Ltd. 63,143.03 4,386.65 -0.1%
Torrent Pharmaceuticals Ltd. 52,359.20 1,548.75 +0.2%
Abbott India Ltd. 40,610.60 19,206.75 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 57.42 944.95 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,699.80 +0.2%
Cipla Ltd. Consolidated 2022-06 36.30 1,118.00 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.26 4,328.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.47 4,386.65 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.37 1,548.75 +0.2%
Abbott India Ltd. Standalone 2022-06 50.22 19,206.75 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.46 944.95 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,699.80 +0.2%
Cipla Ltd. Consolidated 2022-06 4.20 1,118.00 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.58 4,328.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,386.65 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.19 1,548.75 +0.2%
Abbott India Ltd. Standalone 2022-06 13.62 19,206.75 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 944.95 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,699.80 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,118.00 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,328.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,386.65 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,548.75 +0.2%
Abbott India Ltd. Standalone 2022-03 0.00 19,206.75 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 944.95 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,699.80 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,118.00 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,386.65 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,548.75 +0.2%
Abbott India Ltd. Standalone 2022-03 29.95 19,206.75 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 944.95 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,699.80 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,118.00 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,386.65 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,548.75 +0.2%
Abbott India Ltd. Standalone 2022-03 29.95 19,206.75 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 944.95 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,699.80 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,118.00 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,328.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,386.65 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,548.75 +0.2%
Abbott India Ltd. Standalone 2022-03 4,919.27 19,206.75 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 944.95 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,699.80 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,118.00 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,328.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,386.65 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,548.75 +0.2%
Abbott India Ltd. Standalone 2022-03 798.70 19,206.75 +0.1%

FAQ's On Lactose (India) Ltd.

What is Lactose India share price?
Can I buy Lactose India shares now?
What is the Market Cap of Lactose India?
What are the key metrics to analyse Lactose India?
What is the 52 Week High and Low of Lactose India?
What is the trend of Lactose India share price?